Estimated reading time: 2 minutes
Phytovista Laboratories has been given an extension to its ISO 17025 UKAS accreditation.
Goodbody Health Group has announced its subsidiary Phytovista Laboratories has been given an extension to its accreditation with a test to meet Government Chemist and the Advisory Council on the Misuse of Drugs (ACMD) Guidance.
The ISO 17025 UKAS accreditation shows that a lab has adequate quality management systems and is able to provide reliable testing and calibration results.
Executive chairman, Geremy Thomas, stated: “This is another example to show how we as a group not only lead the way in supplying the best quality products but also continue to support the whole CBD industry to put quality and compliance first.”
The Government Chemist highlighted the need for advanced testing for CBD products in its work with the ACMD for the recently published CBD consumer advice. The advice is enabling the UK to lead the way in creating a fully regulated Novel Food consumer CBD market, facilitating consumer choice and confidence.
Advanced testing methodology is desirable to give the required sensitivity and selectivity to reliably detect traces of residues of controlled cannabinoids in consumer CBD products.
Phytovista Laboratories is one of a very small number accredited for this type of testing.
Goodbody Health Group stated that PhytoVista laboratories is now ideally positioned to help CBD companies achieve compliance by providing data in accordance with the ACMD guidance on acceptable levels of controlled cannabinoids in consumer products.